Background. The processes involved in how individuals attribute symptoms to illness are important for understanding the basis of symptom complaints. In a study of patients undergoing travel vaccination, we investigated the association of trait negative affect (NA) and perceived sensitivity to medicines to reported symptoms and symptoms attributed by the patient to treatment.
There is considerable evidence that while large numbers of the population experience physical symptoms on a daily basis, a far smaller number attribute these symptoms to signs of illness or seek medical assistance for their complaints (Verbrugge, 1985) . The process of noticing and interpreting common or everyday symptoms as signs of illness is strongly influenced by psychological factors (Pennebaker, 1982) . This has a number of consequences, including the fact that symptom reports can vary widely between individuals who have the same illness or injury (Weinman, Petrie, Moss-Morris, & Horne, 1996) . Furthermore, symptom reports are often only weakly associated with pathology or disease activity in a number of illnesses, including upper respiratory tract infections (Lane, Barsky, & Goodson, 1988) , asthma (Alonso et al., 1992) , heart disease (Barsky, Cleary, Barnett, Christiansen, & Ruskin, 1994) and arthritis (Summers, Haley, Reveille, & Alarcon, 1988) .
Negative affect (NA) is a factor that has received considerable attention as an explanatory variable in symptom reporting. High trait NA individuals are characterized by the tendency to experience a range of distressing negative emotions such as anxiety and depression. In a number of studies, trait NA has been associated with complaints of physical symptoms and the use of medical care, but unrelated to objective physical illness (Costa & McCrae, 1987; Van Hemert, Bakker, Vandenbrouke, & Valkenburg, 1993; Watson & Pennebaker, 1989) . Individuals scoring high on NA have been shown to report two to three times as many physical symptoms as individuals low on NA (Costa & McCrae, 1980) .
There have been a number of explanations proposed for the relationship between NA and symptom reports, but few studies have examined these relationships in prospective research designs. It has been suggested that in healthy individuals, high NA may cause an increased scanning for symptoms and an increase in the negative interpretations of common symptoms (Affleck, Tennen, Urrows, & Higgins, 1992; Watson & Pennebaker, 1989) . In patients with diagnosed illness, NA has been proposed as increasing vigilance to symptoms seen by the patient as illness-relevant (Cameron, 1997) .
While a number of studies have investigated the role of NA on symptom reporting using both cross-sectional (Watson & Pennebaker, 1989) and prospective (Brown & Moskowitz, 1997 ) designs, we feel the important role of symptom attribution has not been addressed adequately. In most clinical and health care settings, it is the attribution of common symptoms to potentially pathological causes rather than the number of symptoms per se that has an important role in determining patients' help-seeking behaviour (Robbins & Kirmayer, 1991) .
Furthermore, the attribution of common symptoms to illness-related causes is more common in the large group of patients who present with medically unexplained symptoms compared with patients whose symptoms are medically explained (Nimnuan, Hotopf, & Wessely, 2001 ). The factors involved in patients attributing common symptoms to illness-related causes may also be important in the establishment (Cope, David, Pelosi, & Mann, 1994) and maintenance of several chronic psychosomatic illnesses such as chronic fatigue syndrome and fibromyalgia (Moss-Morris & Petrie, 2000) .
Another factor that may influence the perception and reporting of physical symptoms, particularly after the administration of drugs, is patient expectations. In general, individuals tend to amplify symptoms they expect and minimize symptoms they do not expect (Pennebaker, 1982) . Placebo controlled trials have shown that patient expectations about drug effects can influence the subsequent reported side effects (Ross & Olson, 1982) .
Expectations have also been found to be important in the reporting of post-treatment nausea following chemotherapy and this effect has been found to be independent of the patient's level of emotional distress (Montgomery & Bovbjerg, 2000; Roscoe, Hickok, & Morrow, 2001) .
The investigation of how psychological factors influence the attribution of common symptoms presents a number of methodological and ethical difficulties. In most circumstances it is not possible to make individuals ill and see how psychological variables influence the attribution of disease-specific and more general symptoms to an illness. However, there are a few medical interventions that make the examination of this relationship possible and one such example is the immunization of travellers to reduce the risk of vaccine preventable diseases while overseas.
In this study we investigated the effect of trait NA and perceived sensitivity to medicines on symptoms reported following vaccination. In a prospective design, assessments of symptoms and symptom attributions were made immediately after and a week following the treatment. We were particularly interested in the effect of NA and perceived sensitivity to medicines on the attributions of non-vaccination symptoms to the vaccination therapy. As well as NA and perceived sensitivity to medicines, we also evaluated the relationship of recent symptoms, self-reported health and doctor visits to the outcome variables.
Method
Participants Consecutive patients attending a traveller's medical centre for vaccination prior to overseas travel were recruited into the study. With informed consent and ethics committee approval, 121 patients having vaccinations at the centre agreed to participate in the study; only one patient refused. The sample was predominately European (87%) and comprised 64 males and 57 females with a mean age of 32.9 years (SD=12.4).
Procedure
After obtaining informed consent, the research assistant administered a short prevaccination questionnaire in the clinic. During their consultation most patients received two or three vaccinations from the following list, depending on their travel destination: hepatitis A, hepatitis B, poliomyelitis, tetanus, typhoid and yellow fever. After participants received their vaccinations, the clinic required patients to wait for 20 min in case of anaphylaxis or other serious side effects. Following this 20-min period, participants completed a symptom checklist. Seven days later participants were contacted by the research assistant and completed a further symptom checklist by phone. All 121 participants provided data at the seven-day follow-up.
Measures
Pre-vaccination questionnaire Negative affect. The Positive and Negative Affect Schedule (PANAS) was used to assess trait negative affectivity. The 10 negative PANAS adjectives (e.g. distressed, nervous) were rated on a 5-point scale from 'not at all' to 'extremely' for how participants feel in general. The scale has shown high levels of reliability and association with other measures of distress and psychopathology (Watson, Clark, & Tellegen, 1988) .
Symptom reports. A modified version of the Subjective Health Complaint Scale (Eriksen, Ihlebaek, & Ursin, 1999 ) was used to assess symptom reports. Eight items from the original scale were dropped because of overlap with other questionnaire scales. Participants were asked to mark how often they had experienced 21 physical symptoms (e.g. back pain, headache, dizziness) in the previous month on a 4-point scale from 'not at all' to 'a lot'. Doctor visits. Participants were asked how many times they had visited a GP or doctor in the previous 12 months.
Perceived sensitivity to medicines. We assessed patients' beliefs about their sensitivity to the effects of medication and medical treatments using the Sensitive Soma Scale (Horne et al., 2003) . This five-item scale is designed to assess perceived sensitivity to medicines. The scale includes items such as 'My body is very sensitive to medicines' and 'I usually have a stronger reaction to medicines than most people', which are rated on a 5-point scale from 'strongly disagree' to 'strongly agree'. Internal consistency was high in this sample with a Cronbach's alpha of .94.
Self-rated health. This was assessed by a single item, 'Compared to the person in excellent health, how would you rate your health at the present time?', rated on a 7-point scale from 'terrible' to 'excellent'.
Symptom checklist after vaccination
Twenty minutes following vaccination, participants completed a 17-item symptom checklist with the research assistant. This scale included specific vaccination items such as 'pain or tenderness at injection site' as well as more general somatic symptoms such as 'headache'. The items in this scale are presented in Table 1 . The instructions were as follows:
I am interested in any symptoms you have had since your vaccination. I will read a list of symptoms and I firstly want to know if you have experienced that symptom. If you have experienced the symptom, I will ask you whether you think it may be due to the vaccination. It is important to tell me if you have experienced any of the symptoms regardless if you think it may be due to the vaccination.
Each symptom was recorded as being present or not and whether it was attributed to the vaccination by the patient.
Telephone questionnaire at seven days Similar instructions were used for the assessment after seven days using a 20-item checklist-17 items from the 20-min checklist plus the following additional items: upset stomach, diarrhoea and disturbed sleep. Participants were asked whether they had experienced any of these symptoms in the previous seven days and also whether the symptom was attributed to the vaccination.
Symptom attribution measures
The symptom checklists at both time points were divided into two scales: vaccination symptoms attributed to the vaccination treatment and general symptoms attributed to the vaccination. Immediately following the vaccination, the vaccination symptom scale consisted of the following four symptoms: pain or tenderness at injection site; swelling at injection site; itchiness at injection site; and redness at injection site. At the seven-day assessment, the vaccination scale included these four items as well as 'aching muscles' and 'fatigue or extra tiredness' consistent with the symptoms expected from the travel vaccines given (Barnett, Rey, & Chen, 2001 ). The remaining symptoms at both assessments attributed to the vaccination were summed to produce two general symptom scales.
Results
The most common reported symptom immediately following vaccination was pain at the injection site. At the seven-day follow-up period, pain at injection site and aching muscles were the most common symptoms reported followed by fatigue or extra tiredness (see Table 1 ). A number of symptoms were reported at a higher level a week later than at the 20-min assessment. These included aching muscles reported by 24% of the sample after 20 min and 41.3% after seven days. Fatigue or extra tiredness also increased markedly from 7.4% at 20 min to 28.9% at seven days. Participants were generally more likely to attribute symptoms to the vaccination at seven days than at the initial 20-min assessment. The relationships between the psychological variables and the number of reported symptoms at 20 min and seven days was explored initially by using correlational analysis. Table 2 shows that the number of symptoms reported at 20 min was significantly correlated with both perceived sensitivity to medicines and reported symptoms over the past four weeks. Reported symptoms seven days later were also significantly related to perceived sensitivity to medicines and NA. Attributing symptoms to the vaccination at 20 min was unrelated to NA but significantly associated with both perceived sensitivity to medicines and symptoms in the previous month. Seven days later, symptoms attributed to the vaccination were significantly correlated with NA.
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In order to further examine the factors associated with the process of attributing general symptoms to the vaccination, participants were divided into three groups on the basis of whether they attributed no symptoms to the vaccination, only vaccination symptoms, or both vaccination and general symptoms. At the 20-min assessment, 54% of participants did not attribute any symptoms to the vaccination while 21% attributed one or more of the vaccination symptoms to the vaccination, and 25% attributed both vaccination and other symptoms on the list to the vaccination. At the seven-day assessment, 39% of participants did not attribute any symptom to the vaccination, 35% attributed one or more of the vaccination symptoms to the vaccination and 26% attributed both vaccination and any other symptoms on the list to the vaccination. The differences between these three groups on the independent variables were assessed by one-way ANOVA and by Kruskal-Wallis test, in the case of GP visits in the past year, and these results are presented in Table 3 .
The results in Table 3 show an interesting pattern. The attribution of general physical symptoms to the vaccination immediately following the treatment is characteristic of those with high perceived sensitivity to medicines. However, seven days later a different pattern emerges in that the attribution of general symptoms is most strongly related to NA. High levels of NA are associated with the tendency to attribute general symptoms to the vaccination seven days earlier. The data show that perceived sensitivity to medicines is important in predicting shortterm physical complaints, but over the long term, trait NA influences individuals' attribution of common symptoms to the vaccination therapy.
Discussion
The results of this study show that the number of symptoms reported immediately following vaccination are significantly associated with patients' perceived sensitivity to medicines and the number of symptoms in the previous month, while the number of symptoms at seven days is associated with higher levels of both perceived sensitivity and NA. The pattern of symptoms attributed to the vaccination shows that while perceived sensitivity to medicines is important over the short-term, NA plays a much more important role when symptoms attributed to the vaccination are measured over a longer period of time. Over this period, NA seems to operate by increasing the tendency to misattribute general symptoms to the effects of the treatment.
The results suggest that NA does not cause an increase in the reporting of physical symptoms in an illness or intervention that causes highly specific or immediate symptoms. However, when the physical effects of the illness or intervention are either more vague or delayed, then NA increases the tendency for irrelevant somatic Symptoms following vaccination 107 cues to be misattributed to the illness or intervention. Our findings are consistent with a previous study of volunteers exposed to a respiratory virus (Cohen, Doyle, Skoner, & Fireman, 1995; Feldman, Cohen, Doyle, Skoner, & Gwaltner, 1999) . In this study, trait NA was associated with higher rates of physical symptom complaints following viral exposure, but this relationship was independent of whether participants had objective disease. The higher level of reported symptoms by higher NA participants was more consistent with a failure to discriminate between cold and other symptoms rather than showing increased sensitivity to bodily complaints or a hypochondriacal reaction. In another study, NA was shown to lead asthma patients to associate a wider range of symptoms to their illness and increase the use of reliever medication (Main, MossMorris, Booth, Kaptein, & Kolbe, 2003) . The importance of patients' perceptions of their sensitivity to medicines predicting short-term symptoms and attributions is consistent with other research showing beliefs, and expectations shape the noticing and reporting of symptoms (Croyle & Sande, 1988; Petrie & Weinman, 1997) . In a study of aspirin treatment for unstable angina, the participant information form at two of the study centres specifically listed 'gastrointestinal irritation' as a possible side effect, but the third centre did not. The centres that listed gastrointestinal irritation had six times as many patients withdraw from the study because of gastrointestinal distress than the other centre. Furthermore, patients at the first centres had significantly higher rates of gastrointestinal symptoms but no higher rates of gastrointestinal disease (Myers, Cairn, & Singer, 1987) .
Perceived sensitivity clearly has a strong effect immediately following treatment. It seems to operate first by priming the patient to notice any unusual physical symptoms, and secondly to interpret these sensations in the context of a reaction to treatment. A study of patients with food allergies found that when patients were injected with saline which was described as an allergen, a quarter of patients developed allergic symptoms (Jewett, Fein, & Greenberg, 1990) . Essentially, patients with high levels of perceived sensitivity to medicines have a broad and readily activated schema in which to notice and attribute any symptoms close to the treatment as medication-related.
It is surprising that to date research on perceived sensitivity to medicine has not received more attention, as in clinical situations many patients complain about being over-sensitive to prescription medication and there also seems to be some evidence that perceived sensitivity to medicines may be increasing (Petrie & Wessely, 2002) . Patients' beliefs about their sensitivity are linked closely to their concerns about taking particular types of medication and adherence to treatment regimens (Home, 1997). Furthermore, many patients identify negative reactions to prescription medicines as a primary reason for using alternative medicines (Furnham & Smith, 1988) . The study of symptoms following vaccination offers a unique clinical setting in which to study attribution symptom processes.
This study provides further support for the close relationship between trait NA and symptom reporting. Consistent with previous research, high NA was associated with poorer self-rated health, more doctor visits and a greater number of reported symptoms over the previous month (Watson & Pennebaker, 1989) . Data following vaccination showed that NA did not strongly influence immediate symptom reporting or the immediate attribution of symptoms. However, at seven days, high trait NA participants attributed many more non-specific symptoms to the effect of the vaccination. This process of attributing general somatic complaints to the vaccination suggests that the attribution of normal daily symptoms to illnesses or non-normalizing causes may be an important mechanism in the relationship between NA and symptom reporting.
